Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul A Carpenter

Showing results (81-90 of 178) with videos related to

Pageof 18
Sort By:
Transplantation and Cellular Therapy|June 14, 2025
American Society for Transplantation and Cellular Therapy Series #10: Management of Parainfluenza and Human Metapneumovirus Infections in Hematopoietic Cell Transplantation and Cellular Therapy RecipientsMarjorie Vieira Batista, Firas El Chaer, Janet A Englund, et al.
Blood|April 4, 2002
A humanized non-FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host diseasePaul A Carpenter, Frederick R Appelbaum, Lawrence Corey, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 30, 2017
Association of Plasma CD163 Concentration with De Novo-Onset Chronic Graft-versus-Host DiseaseYoshihiro Inamoto, Paul J Martin, Sophie Paczesny, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 9, 2019
Preventing Measles in Immunosuppressed Cancer and Hematopoietic Cell Transplantation Patients: A Position Statement by the American Society for Transplantation and Cellular TherapySteven A Pergam, Janet A Englund, Mini Kamboj, et al.
Transplantation and Cellular Therapy|September 20, 2024
Associations Between Demographic Factors, Clinical Variables, Social Determinants of Health, Vaccine Hesitancy, Vaccine Behavior, and Revaccination Status: A Survey of Adult HCT Survivors in the United StatesMihkai M Wickline, Paul A Carpenter, Jeffrey R Harris, et al.
Vaccine|October 22, 2024
Vaccine hesitancy and routine revaccination among adult HCT survivors in the United States: A convergent mixed methods analysisMihkai M Wickline, Paul A Carpenter, Jeffrey R Harris, et al.
Transplantation and Cellular Therapy|June 18, 2022
Hematopoietic Cell Transplantation in the Treatment of Pediatric Acute Myelogenous Leukemia and Myelodysplastic Syndromes: Guidelines from the American Society of Transplantation and Cellular TherapyKatherine Tarlock, Maria Luisa Sulis, Joseph H Chewning, et al.
Transplantation and Cellular Therapy|October 2, 2023
American Society of Transplantation and Cellular Therapy Series: #7 - Management of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant RecipientsFiras El Chaer, Daniel R Kaul, Janet A Englund, et al.
Frontiers in Oncology|May 8, 2026
Autologous and allogeneic hematopoietic cell transplantation in children and adults with high-risk anaplastic large cell lymphomaNatalie L Smith, Corinne Summers, Ted Gooley, et al.
Blood Advances|May 18, 2022
Long-term patient-reported neurocognitive outcomes in adult survivors of hematopoietic cell transplantNatalie L Wu, Amanda I Phipps, Kevin R Krull, et al.
Pageof 18

Showing results (81-90 of 178) with videos related to

Sort By:
Pageof 18
Transplantation and Cellular Therapy|June 14, 2025
American Society for Transplantation and Cellular Therapy Series #10: Management of Parainfluenza and Human Metapneumovirus Infections in Hematopoietic Cell Transplantation and Cellular Therapy RecipientsMarjorie Vieira Batista, Firas El Chaer, Janet A Englund, et al.
Blood|April 4, 2002
A humanized non-FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host diseasePaul A Carpenter, Frederick R Appelbaum, Lawrence Corey, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 30, 2017
Association of Plasma CD163 Concentration with De Novo-Onset Chronic Graft-versus-Host DiseaseYoshihiro Inamoto, Paul J Martin, Sophie Paczesny, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 9, 2019
Preventing Measles in Immunosuppressed Cancer and Hematopoietic Cell Transplantation Patients: A Position Statement by the American Society for Transplantation and Cellular TherapySteven A Pergam, Janet A Englund, Mini Kamboj, et al.
Transplantation and Cellular Therapy|September 20, 2024
Associations Between Demographic Factors, Clinical Variables, Social Determinants of Health, Vaccine Hesitancy, Vaccine Behavior, and Revaccination Status: A Survey of Adult HCT Survivors in the United StatesMihkai M Wickline, Paul A Carpenter, Jeffrey R Harris, et al.
Vaccine|October 22, 2024
Vaccine hesitancy and routine revaccination among adult HCT survivors in the United States: A convergent mixed methods analysisMihkai M Wickline, Paul A Carpenter, Jeffrey R Harris, et al.
Transplantation and Cellular Therapy|June 18, 2022
Hematopoietic Cell Transplantation in the Treatment of Pediatric Acute Myelogenous Leukemia and Myelodysplastic Syndromes: Guidelines from the American Society of Transplantation and Cellular TherapyKatherine Tarlock, Maria Luisa Sulis, Joseph H Chewning, et al.
Transplantation and Cellular Therapy|October 2, 2023
American Society of Transplantation and Cellular Therapy Series: #7 - Management of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant RecipientsFiras El Chaer, Daniel R Kaul, Janet A Englund, et al.
Frontiers in Oncology|May 8, 2026
Autologous and allogeneic hematopoietic cell transplantation in children and adults with high-risk anaplastic large cell lymphomaNatalie L Smith, Corinne Summers, Ted Gooley, et al.
Blood Advances|May 18, 2022
Long-term patient-reported neurocognitive outcomes in adult survivors of hematopoietic cell transplantNatalie L Wu, Amanda I Phipps, Kevin R Krull, et al.
Pageof 18